Gracey M
Aboriginal Health Unit, Health Department of Western Australia, Perth.
Acta Paediatr Jpn. 1991 Jun;33(3):279-83. doi: 10.1111/j.1442-200x.1991.tb01555.x.
Over the past 20 years there have been many important advances in knowledge about diarrhoeal diseases of children. Of these, the development of oral rehydration therapy (ORT), has been outstanding. This is based on the observation that intestinal sodium transport is enhanced by glucose transport in the small intestine and that this sodium-coupled mechanism for glucose and water transport remains intact in the enterotoxigenic diarrhoeas despite the net secretory effects of bacterial enterotoxins on the small intestinal epithelium. The World Health Organisation has adopted ORT and strongly promoted its application for treatment of diarrhoeal diseases, particularly in developing countries. This has resulted in a drop in diarrhoeal disease mortality and the application of this treatment has been described in an Editorial in the Lancet as "potentially the most important medical advance this century".
在过去20年里,关于儿童腹泻病的知识有了许多重要进展。其中,口服补液疗法(ORT)的发展尤为突出。这一疗法基于以下观察结果:小肠中葡萄糖的转运可增强肠道对钠的转运,并且尽管细菌肠毒素对小肠上皮细胞有净分泌作用,但这种葡萄糖和水的钠偶联转运机制在产肠毒素性腹泻中仍然完好无损。世界卫生组织已采用口服补液疗法,并大力推广其在腹泻病治疗中的应用,尤其是在发展中国家。这使得腹泻病死亡率有所下降,《柳叶刀》杂志的一篇社论将这种治疗方法的应用描述为“可能是本世纪最重要的医学进展”。